Latest Breaking News On - Alliance for clinical trials in oncology - Page 5 : comparemela.com

Novartis eyes $1B Lutathera acceleration with trial win in newly diagnosed neuroendocrine tumors

Novartis eyes $1B Lutathera acceleration with trial win in newly diagnosed neuroendocrine tumors
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

United statesSimron singhAlliance for clinical trials in oncologyUniversity of torontoClinical oncology gastrointestinal cancersFierce pharmaClinical trials

Haystack Oncology and Alliance Foundation Trials collaborate to use Haystack MRD™ technology in phase II clinical trial for unresectable stage III NSCLC

BALTIMORE, Jan. 8, 2024 /PRNewswire/ Haystack Oncology, a Quest Diagnostics company, has entered into a collaboration with Alliance Foundation Trials, LLC for research use of Haystack.

United statesEteläuomen läiDan edelsteinDavid kozonoAlliance foundation trialsQuest diagnosticsJohns hopkins school of medicineOncology committee coAlliance immunoRoche groupAlliance for clinical trials in oncologyHaystack oncologyVice presidentGeneral managerAlliance immuno oncology committeeJohns hopkins school

Exelixis Announces Preliminary Fiscal Year 2023 Financial Results, Provides 2024 Financial Guidance, and Outlines Key Priorities and Milestones for 2024

– Cabozantinib franchise achieves approximately $1.630 billion in preliminary U.S. net product revenues for fiscal year 2023 – – Fiscal year 2024 net product revenues guidance of $1,650.

United statesGail eckhardtMichaelm morrisseyMaryc beckerleAlanm garberDrug administrationAlliance for clinical trials in oncologyOncological sciencesUpcoming development milestonesCurrent developmentExelixis incHuntsman cancer institutePharmaceuticals incExchange commissionUnited states district courtMillion share repurchase program

Exelixis Announces Preliminary Fiscal Year 2023 Financial Results, Provides 2024 Financial Guidance, and Outlines Key Priorities and Milestones for 2024

Exelixis Announces Preliminary Fiscal Year 2023 Financial Results, Provides 2024 Financial Guidance, and Outlines Key Priorities and Milestones for 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesGail eckhardtMichaelm morrisseyChris sennerHal mackinsSusan hubbardMaryc beckerleAlanm garberAmerican society of clinical oncologyCurrent developmentUpcoming development milestonesUnited states district courtUniversity of utahMillion share repurchase programCollege danl duncan comprehensive cancer centerTranslational research

Once reluctant, new NIH chief Monica Bertagnolli has embraced her leading role

Once reluctant, new NIH chief Monica Bertagnolli has embraced her leading role
science.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from science.org Daily Mail and Mail on Sunday newspapers.

University of utahUnited statesMonica bertagnolliElad sharonLawrence tabakMary beckerleDana farberJoe bidenSuzanne georgeFrancis collinsBernie sandersNational cancer instituteInstitute of medicineNational cancer planDana farber cancer institutePrinceton university